COMPANY DESCRIPTION
Flagship Labs 109, Inc. (FL109) is pioneering the use of artificial intelligence, physics and hardware to transform the way we see biology. FL109 is a privately held biotech, conceived by Flagship Pioneering, which brings the courage, long-term vision, and resources needed to realize unreasonable results. Become part of our mission-driven team and help envision the future of science.
THE ROLE
FL109 is seeking innovative and driven professionals to join our interdisciplinary team. As a member of our early-stage company, you will play a pivotal role in developing and deploying state-of-the-art AI solutions that integrate artificial intelligence, physics, and hardware to transform our understanding of molecular biology. Your contributions will be essential in building scalable platforms, managing extensive datasets, and collaborating across diverse teams to achieve groundbreaking results.
We’re looking for amazing talent in these spaces:
- AI
- Software engineering
- Automation
- Physics
- Hardware engineering
#LI-MB1
Top Skills
What We Do
Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability.
Since its launch in 2000, the firm has applied a unique, hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $30 billion in aggregate value. To date, Flagship is backed by >$3 billion of aggregate capital commitments, of which over $1.5 billion has been deployed toward the founding and growth of its pioneering companies alongside >$10 billion of follow-on investments from other institutions.
The current Flagship ecosystem includes Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Moderna Therapeutics (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS).
